ALNYLAM PHARMACEUTICALS, INC. Effect on Future Earnings, Offset Amount
ALNYLAM PHARMACEUTICALS, INC. (ALNY) reported Effect on Future Earnings, Offset Amount of $20.00 million for the 9-month period ending 2012-09-30, per its 10-Q filed 2012-11-05.
Discontinued › Notes › Restructuring and Related Activities
us-gaap:EffectOnFutureEarningsOffsetAmount · last filed 2012-11-05
- ALNYLAM PHARMACEUTICALS, INC. effect on future earnings, offset amount for the quarter ending 2012-09-30 was $0.00.
| Period end | Effect on Future Earnings, Offset Amount 3 month | Effect on Future Earnings, Offset Amount 6 month | Effect on Future Earnings, Offset Amount 9 month |
|---|---|---|---|
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-05 | $20.00M 10-Q · filed 2012-11-05 | |
| 2012-06-30 | $20.00M 10-Q · filed 2012-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |